Gabapentin dosage for anxiety and depression
Pro Research Analysisby 
Searched over 200M research papers
Gabapentin Dosage for Anxiety and Depression
Gabapentin for Anxiety: Dosage and Efficacy
Gabapentin, an antiepileptic drug, has shown promise in treating anxiety disorders. Studies have explored various dosages to determine its effectiveness and safety. A randomized controlled trial involving breast cancer survivors compared gabapentin at 300 mg/day and 900 mg/day against a placebo. Results indicated that both dosages significantly reduced anxiety levels at 4 and 8 weeks, with the 300 mg/day dosage showing the best outcomes for most patients 25. Another study on perioperative anxiety in pediatric patients found that gabapentin at 15 mg/kg preoperatively and 7.5 mg/kg postoperatively significantly reduced anxiety scores compared to a placebo . Additionally, a single 1200 mg preoperative dose of gabapentin was effective in reducing preoperative anxiety without causing sedation or memory impairment .
Gabapentin for Depression: Dosage and Efficacy
Gabapentin has also been investigated as an adjunctive treatment for depression, particularly in treatment-resistant cases. A retrospective chart review of patients with depressive disorders who did not respond to conventional antidepressants found that adding gabapentin (mean dose of 904 mg/day, range 300-1800 mg/day) led to significant improvements in clinical state, with 37% of patients responding positively by the end of the trial . Another study on bipolar disorder patients with incomplete responses to other mood stabilizers reported that gabapentin (mean dose of 1310 mg/day) improved depressive symptoms, including anxiety and social functioning .
Combined Anxiety and Depression Treatment
Gabapentin's dual efficacy in treating both anxiety and depression makes it a valuable option for patients experiencing both conditions. In cases of anxiety induced by simulated public speaking, gabapentin at 400 mg and 800 mg doses reduced anxiety and hostility scores, suggesting its potential for broader anxiolytic use . Furthermore, gabapentin's minimal side effects and lack of significant drug interactions make it an attractive alternative to traditional anxiolytics and antidepressants .
Conclusion
Gabapentin has demonstrated efficacy in treating both anxiety and depression, with optimal dosages varying based on the specific condition and patient population. For anxiety, dosages of 300 mg/day to 900 mg/day have shown significant benefits, while for depression, adjunctive doses around 900 mg/day to 1310 mg/day have been effective. Its dual action on anxiety and depression, combined with a favorable side effect profile, positions gabapentin as a versatile treatment option for patients with these mood disorders.
Sources and full results
Most relevant research papers on this topic